AI Integration With Jingyi Qianxun Will Improve Efficiency In Healthcare Services

Published
09 Mar 25
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
HK$45.99
17.2% overvalued intrinsic discount
31 Jul
HK$53.90
Loading
1Y
162.3%
7D
5.8%

Author's Valuation

HK$46.0

17.2% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 9.85%

Shared on23 Apr 25
Fair value Increased 0.29%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 1.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 2.01%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 1.38%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 8.48%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 2.49%